Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Return on Equity (2016 - 2018)

Historic Return on Equity for Armata Pharmaceuticals (ARMP) over the last 5 years, with Q3 2018 value amounting to 0.81%.

  • Armata Pharmaceuticals' Return on Equity rose 12900.0% to 0.81% in Q3 2018 from the same period last year, while for Sep 2018 it was 0.81%, marking a year-over-year increase of 12900.0%. This contributed to the annual value of 1.47% for FY2017, which is 2100.0% up from last year.
  • Latest data reveals that Armata Pharmaceuticals reported Return on Equity of 0.81% as of Q3 2018, which was up 12900.0% from 0.03% recorded in Q2 2018.
  • In the past 5 years, Armata Pharmaceuticals' Return on Equity ranged from a high of 3.37% in Q3 2014 and a low of 79.08% during Q1 2015
  • Over the past 5 years, Armata Pharmaceuticals' median Return on Equity value was 0.89% (recorded in 2016), while the average stood at 5.15%.
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by -798700bps in 2015, then soared by 779400bps in 2016.
  • Armata Pharmaceuticals' Return on Equity (Quarter) stood at 5.86% in 2014, then skyrocketed by 87bps to 0.74% in 2015, then tumbled by -102bps to 1.49% in 2016, then grew by 0bps to 1.48% in 2017, then surged by 45bps to 0.81% in 2018.
  • Its Return on Equity was 0.81% in Q3 2018, compared to 0.03% in Q2 2018 and 0.05% in Q1 2018.